|
| 37249267 | Impact of Subgroup Distribution on Seasonality of Human Respiratory Syncytial Virus: A Global Systematic Analysis. | J Infect Dis | 2024 |
| 35952703 | Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. | Lancet Infect Dis | 2023 |
| 37751795 | TNFAIP3-interacting protein 1 polymorphisms and their association with symptomatic human respiratory syncytial virus infection and bronchiolitis in infants younger than one year from South Africa: A case-control study. | Int J Infect Dis | 2023 |
| 37624826 | Healthcare utilization during the first two waves of the COVID-19 epidemic in South Africa: A cross-sectional household survey. | PLoS One | 2023 |
| 37745916 | Knowledge, attitudes, practices and intention to get vaccinated against COVID-19: results from a cross-sectional survey in three peri-urban communities in South Africa. | Pan Afr Med J | 2023 |
| 37952237 | Association of HIV Exposure and HIV Infection With In-hospital Mortality Among Hospitalized Infants <1 Year of Age, South Africa, 2016-2018. | J Pediatric Infect Dis Soc | 2023 |
| 37652071 | Long COVID in low-income and middle-income countries: the hidden public health crisis. | Lancet | 2023 |
| 38090227 | Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa. | Influenza Other Respir Viruses | 2023 |
| 37968614 | Transient increased risk of influenza infection following RSV infection in South Africa: findings from the PHIRST study, South Africa, 2016-2018. | BMC Med | 2023 |
| 35717655 | Unmasking Pneumococcal Carriage in a High Human Immunodeficiency Virus (HIV) Prevalence Population in two Community Cohorts in South Africa, 2016-2018: The PHIRST Study. | Clin Infect Dis | 2023 |
| 37055799 | The economic burden of RSV-associated illness in children agedâ¿¿<â¿¿5Â years, South Africa 2011-2016. | BMC Med | 2023 |
| 37211271 | The attributable fraction of respiratory syncytial virus among patients of different ages with influenza-like illness and severe acute respiratory illness in a high HIV prevalence setting, South Africa, 2012-2016. | Int J Infect Dis | 2023 |
| 37038125 | The burden of RSV-associated illness in children agedâ¿¿<â¿¿5Â years, South Africa, 2011 to 2016. | BMC Med | 2023 |
| 37004062 | Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa. | BMC Med | 2023 |
| 37195977 | Differential in-hospital mortality and intensive care treatment over time: Informing hospital pathways for modelling COVID-19 in South Africa. | PLOS Glob Public Health | 2023 |
| 36587841 | A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. | Int J Infect Dis | 2023 |
| 36853101 | Co-testing a single sputum specimen for TB and SARS-CoV-2. | Int J Tuberc Lung Dis | 2023 |
| 36692337 | Incidence and Transmission Dynamics of Bordetella pertussis Infection in Rural and Urban Communities, South Africa, 2016â¿¿2018. | Emerg Infect Dis | 2023 |
| 36648247 | Changing Epidemiology of COVID-19 in Children and Adolescents Over Four Successive Epidemic Waves in South Africa, 2020-2022. | J Pediatric Infect Dis Soc | 2023 |
| 36807683 | When to update COVID-19 vaccine composition. | Nat Med | 2023 |
| 36436752 | Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa. | Int J Infect Dis | 2023 |
| 36930672 | COVID-19 infection, reinfection, and the transition to endemicity. | Lancet | 2023 |
| 36797259 | Optimal age targeting for pneumococcal vaccination in older adults; a modelling study. | Nat Commun | 2023 |
| 36453094 | Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa. | Clin Infect Dis | 2023 |
| 35925613 | Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 From Adult Index Cases With and Without Human Immunodeficiency Virus in South Africa, 2020-2021: A Case-Ascertained, Prospective, Observational Household Transmission Study. | Clin Infect Dis | 2023 |
| 34796674 | Epidemiology of SARS-CoV-2 infection and SARS-CoV-2 positive hospital admissions among children in South Africa. | Influenza Other Respir Viruses | 2022 |
| 37994361 | Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study. | Gates Open Res | 2022 |
| 35839815 | Culture-confirmed neonatal bloodstream infections and meningitis in South Africa, 2014-19: a cross-sectional study. | Lancet Glob Health | 2022 |
| 35700877 | Pathogens detected using a syndromic molecular diagnostic platform in patients hospitalized with severe respiratory illness in South Africa in 2017. | Int J Infect Dis | 2022 |
| 35606732 | SARS-CoV-2 cases reported from long-term residential facilities (care homes) in South Africa: a retrospective cohort study. | BMC Public Health | 2022 |
| 35597249 | Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study. | Lancet Glob Health | 2022 |
| 35567586 | COVID-19 vaccine hesitancy in rural South Africa: Deepening understanding to increase uptake and access. | J Glob Health | 2022 |
| 35783465 | Leveraging epidemiology as a decision support tool during the COVID-19 epidemic in South Africa. | S Afr Med J | 2022 |
| 35780802 | Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa. | Lancet | 2022 |
| 35355414 | Costs of seasonal influenza vaccination in South Africa. | Influenza Other Respir Viruses | 2022 |
| 36447608 | Effectiveness of Influenza Vaccination of Pregnant Women for Prevention of Maternal and Early Infant Influenza-Associated Hospitalizations in South Africa: A Prospective Test-Negative Study. | Open Forum Infect Dis | 2022 |
| 36570970 | Risk Factors for Severe Coronavirus Disease 2019 Among Human Immunodeficiency Virus-Infected and -Uninfected Individuals in South Africa, April 2020-March 2022: Data From Sentinel Surveillance. | Open Forum Infect Dis | 2022 |
| 36214039 | Undiagnosed comorbidities among individuals hospitalised with COVID-19 in South African public hospitals. | S Afr Med J | 2022 |
| 35934172 | Case-fatality and sequelae following acute bacterial meningitis in South Africa, 2016 through 2020. | Int J Infect Dis | 2022 |
| 36065332 | COVID-19 hospital admissions and mortality among healthcare workers in South Africa, 2020-2021. | IJID Reg | 2022 |
| 35961348 | Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study. | Lancet Glob Health | 2022 |
| 36032973 | Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa. | medRxiv | 2022 |
| 36057266 | Methods for early characterisation of the severity and dynamics of SARS-CoV-2 variants: a population-based time series analysis in South Africa. | Lancet Microbe | 2022 |
| 36263375 | Coronavirus Host Genomics Study: South Africa (COVIGen-SA). | Glob Health Epidemiol Genom | 2022 |
| 36195617 | Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa. | Nat Commun | 2022 |
| 35982666 | Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four waves. | medRxiv | 2022 |
| 36347458 | High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa. | Int J Infect Dis | 2022 |
| 35320701 | SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa. | Emerg Infect Dis | 2022 |
| 35289632 | Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. | Science | 2022 |
| 35313577 | The impact of COVID-19 non-pharmaceutical interventions on future respiratory syncytial virus transmission in South Africa. | medRxiv | 2022 |